Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  mucositis
Country:  U.S.A.
Trial Type:  Supportive care
Trial Status:  Active
Results 1-22 of 22 for your search:
Start Over
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
Phase: Phase III
Type: Supportive care
Status: Active
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: CASE6Z13, NCI-2013-01800, P30CA043703, NCT01951885
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2013-0308, NCI-2014-00917, NCT01952847
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: A221304, U10CA037447, UG1CA189823, NCI-2014-01877, NCT02229539
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 603EUSA03, NCT00901732
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB201400628, NCT02326675
Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: UW14068, NCI-2015-00576, P30CA014520, 2015-0062, NCT02434146
Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: WVU041011, NCT01566448
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: D1022, NCT01653327
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IDR-OM-01, NCT02013050
Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With PTCL
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPI-FOL-14-201, NCT02106650
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13026, CRAD001JUS240T, NCT02229136
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00072091, NCI-2014-02112, WINSHIP2645-14, NCT02273752
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase: Phase II
Type: Supportive care
Status: Active
Age: 55 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLT008-03, NCT02282215
Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 20 to 85
Sponsor: Other
Protocol IDs: 12.0220, NCT01668849
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GT-001, NCT01921426
TRIAD Burden of Illness Mucositis Study
Phase: No phase specified
Type: Natural history/Epidemiology, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: No. 200509024, NCT00336609
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HSC20050218H, NCT00575809
Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HP-00053319, GCC1229, NCT01883908
Observational Study of Dental Outcomes in Head and Neck Cancer Patients
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-040-E, 1U01DE022939-01, NCT02057510
Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 1 to 22
Sponsor: Other
Protocol IDs: H-33119, NCT02076997
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC13C2, NCI-2014-00865, Mod13-007632-07, P30CA015083, NCT02123511
A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 43313, NCT02277548
Start Over